Cargando…
Novel Nasal in situ Gelling System for Treatment of Sinusitis
In situ gelling systems based on temperature-dependent phase transition containing pheniramine and phenylephrine were developed using combination of Poloxamers, different cellulose polymers (HPMC) and xanthan gum. The formulations were tested for in vitro gelation, appearance, pH, drug content, in v...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846489/ |
_version_ | 1782179483491500032 |
---|---|
author | Mehta, M. R. Surve, S. A. Menon, M. D. |
author_facet | Mehta, M. R. Surve, S. A. Menon, M. D. |
author_sort | Mehta, M. R. |
collection | PubMed |
description | In situ gelling systems based on temperature-dependent phase transition containing pheniramine and phenylephrine were developed using combination of Poloxamers, different cellulose polymers (HPMC) and xanthan gum. The formulations were tested for in vitro gelation, appearance, pH, drug content, in vitro drug release, mucoadhesive strength, preservative efficacy and stability. In vitro release studies revealed significant prolonged released of both drugs up to 24 h as against only 2 h with drug solution. Formulations were found to stable over period of 3 months. In vivo nasal residence time of in situ gel by gamma scintigraphy was found to be significantly higher (6 h) in comparison to drug solution (15 min). It can be concluded that Poloxamers in combination with HPMC are suitable to develop stable, safe in situ temperature-based mucoadhesive gelling systems with prolonged nasal residence time. |
format | Text |
id | pubmed-2846489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-28464892010-04-06 Novel Nasal in situ Gelling System for Treatment of Sinusitis Mehta, M. R. Surve, S. A. Menon, M. D. Indian J Pharm Sci Abstract In situ gelling systems based on temperature-dependent phase transition containing pheniramine and phenylephrine were developed using combination of Poloxamers, different cellulose polymers (HPMC) and xanthan gum. The formulations were tested for in vitro gelation, appearance, pH, drug content, in vitro drug release, mucoadhesive strength, preservative efficacy and stability. In vitro release studies revealed significant prolonged released of both drugs up to 24 h as against only 2 h with drug solution. Formulations were found to stable over period of 3 months. In vivo nasal residence time of in situ gel by gamma scintigraphy was found to be significantly higher (6 h) in comparison to drug solution (15 min). It can be concluded that Poloxamers in combination with HPMC are suitable to develop stable, safe in situ temperature-based mucoadhesive gelling systems with prolonged nasal residence time. Medknow Publications 2009 /pmc/articles/PMC2846489/ Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Mehta, M. R. Surve, S. A. Menon, M. D. Novel Nasal in situ Gelling System for Treatment of Sinusitis |
title | Novel Nasal in situ Gelling System for Treatment of Sinusitis |
title_full | Novel Nasal in situ Gelling System for Treatment of Sinusitis |
title_fullStr | Novel Nasal in situ Gelling System for Treatment of Sinusitis |
title_full_unstemmed | Novel Nasal in situ Gelling System for Treatment of Sinusitis |
title_short | Novel Nasal in situ Gelling System for Treatment of Sinusitis |
title_sort | novel nasal in situ gelling system for treatment of sinusitis |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846489/ |
work_keys_str_mv | AT mehtamr novelnasalinsitugellingsystemfortreatmentofsinusitis AT survesa novelnasalinsitugellingsystemfortreatmentofsinusitis AT menonmd novelnasalinsitugellingsystemfortreatmentofsinusitis |